CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia – Hematology – Oncology
CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Clinical Advances in Hematology & Oncology
October 2016, Volume 14, Issue Ten
Marco L. Davila, MD, PhD, and Renier J. Brentjens, MD, PhD
Dr Davila is an associate member in the Department of Blood and Marrow Transplantation and the medical director of the Cell Transfer Facility, both at the H. …